You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Solitary Pancreas Allografts

The Role of Percutaneous Biopsy and Standardized Histologic Grading of Rejection

Paul C. Kuo, MD; Lynt B. Johnson, MD; Eugene J. Schweitzer, MD; David K. Klassen, MD; Edward W. Hoehn-Saric, MD; Matthew R. Weir, MD; Cinthia B. Drachenberg, MD; John C. Papadimitriou, MD, PhD; Stephen T. Bartlett, MD

Arch Surg. 1997;132(1):52-57.


Abstract

Objective
To determine the potential impact of ultrasound-guided percutaneous pancreas allograft biopsy and standardized histologic grading on graft and patient survival in a solitary pancreas transplant program.

Design
Retrospective case series survey.

Setting
Tertiary care, university teaching hospital.

Patients
Thirty-five recipients of solitary pancreas transplants.

Interventions
Percutaneous pancreas allograft biopsies were performed in solitary pancreas transplant recipients.

Main Outcome Measures
Actuarial graft and patient survival, cause of graft loss.

Results
Initiation of ultrasound-guided percutaneous pancreas allograft biopsy with standardized histologic grading is associated with a 70% 1-year graft survival and 93% 1-year patient survival in solitary pancreas transplantation. Acute rejection was responsible for only 11% of cases of graft loss. The presence of endotheliitis, vasculitis, or confluent acinar necrosis is associated with decreased pancreas allograft survival, poor response to corticosteroid therapy, and shortened time interval to ultimate graft loss. Clinical criteria for acute rejection such as elevated serum amylase or lipase levels, 50% decrease in urinary amylase levels, unexplained fever, or hyperglycemia are associated with a positive predictive value of only 72%.

Conclusion
Pancreas allograft biopsy and standardized histologic grading are associated with significantly improved 1-year graft and patient survival in solitary pancreas transplantation.

Arch Surg. 1997;132:52-57



Author Affiliations

From the Departments of Surgery (Drs Kuo, Johnson, Schweitzer, and Bartlett), Medicine (Drs Klassen, Hoehn-Saric, and Weir), and Pathology (Drs Drachenberg and Papadimitriou), University of Maryland Medical Systems, Baltimore.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pancreatic Transplantation: Evaluation and Management
Zaman et al.
J Intensive Care Med 2004;19:127-139.
ABSTRACT  

A 9-Year Experience With 126 Pancreas Transplants With Portal Enteric Drainage
Stratta et al.
Arch Surg 2001;136:1141-1149.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.